LYN and liver disorder: In contrast to Patients 1 and 3 with the truncating mutations, Patient 2 with the LYN missense mutation, p.Y508F, did not develop liver disease suggesting that the truncating mutations that eliminate the 5 terminal amino acids may confer more severe disease.